Home

Home

 

 … Sofinnova Partners sells portfolio company Ethical Oncology Science (EOS) to Clovis Oncology for $200 million upfront and up to an additional $220 million in milestones [+]

 

Sofinnova Partners is an independent venture capital firm based in Paris. Over the past 40 years, the firm has financed and accompanied almost 500 companies.

We invest in start-ups, early-stage companies, corporate spin-offs and occasionally turnaround situations. We invest in Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. We sit on the boards of our portfolio companies, and play an active role from the formation phase alongside entrepreneurs. We invest throughout Europe from our headquarters in Paris with a portion of investments made in the rest of the world.

 

Highlighted Success Stories

novexel corevalve preglem_4-9-2 movetis actelion EOS
 

Featured Investments

MedDay greenbiologics_web reflexion_web pixium_web shockwave_web CelluComp_web


View the complete portfolio